J&J
Shumin Zhang, MD, ScD, is Senior Director Regulatory Real-World Evidence & Epidemiology in Global MedTech Epidemiology and Real-World Data Sciences at Johnson & Johnson. She leads a Regulatory Real-World Evidence and Epidemiology/Oncology team that conducts studies for regulatory purposes and collaborates and partners with the Johnson & Johnson Lung Cancer Initiative on real-world evidence generation and value demonstration. She also plays a leadership role in conducting four U.S. National Evaluation System for health Technology Coordinating Center (NESTcc) real-world evidence test cases of Johnson & Johnson products for label extensions and for proactive post-marketing safety surveillance. She is a member of the Medical Device Innovation Consortium (MDIC)’s Advisory Committee for Data Science and Technology and the NESTcc Research Methods Subcommittee.
Shumin received her Doctor of Science degree in Epidemiology and Nutrition with a minor in Biostatistics from Harvard School of Public Health, her medical degree from Harbin Medical University, and her master's degree from the Chinese Academy of Preventive Medicine. She has over 20 years of experience and extensive expertise in conducting both prospective and retrospective studies using real-world data across industry and academia. In industry, she has worked in both medical device and pharmaceutical sectors and conducted real-world evidence and epidemiologic research supporting products in multiple therapeutic areas, including Oncology, Cardiovascular & Metabolic, Respiratory, and Rare Diseases. In academia, she was Associate Professor of Medicine at Harvard Medical School and Co-Director of Cancer Research in the Division of Preventive Medicine at Brigham and Women’s Hospital. She was the Principal Investigator of multiple grants funded by the NIH/NCI and the American Cancer Society. Shumin has authored or co-authored over 120 peer-reviewed original papers in scientific journals.